Delivery Order SPE2DB22D2211-SPE2DB25FSBSE
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,649.00 to AmerisourceBergen Drug Corp for the supply of Gel-One 30 mg/3 mL syringes. This competitive, firm fixed-price delivery order, issued on July 22, 2025, is scheduled for completion by August 12, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was awarded through open competition to this established...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Gel-One 30 mg/3 mL syringes with a ceiling value of $3,649.00 and an ultimate completion date of August 13, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Gel-One 30 mg/3 ml syringes, a medical device used for joint pain treatment. The contract is a firm fixed-price delivery order with a ceiling value of $6,203.30 and a period of performance through May 22, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This is a $26,806.72 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of GEL-ONE 30 MG/3 ML syringe, a pharmaceutical product, with a period of performance through July 23, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,563,308,862 units of the pharmaceutical product GEL-ONE 30 MG/3 ML SYRINGE 3ML. The $3,527.20 contract has a completion date of January 26, 2024. This delivery order was placed under an existing indefinite delivery contract held by AmerisourceBergen Drug Corp to supply pharmaceuticals and medical supplies to DLA. No set-aside...
- The U.S. Defense Logistics Agency (DLA) awarded a $7,054.40 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide GEL-ONE 30 MG/3 ML SYRINGE 3ML pharmaceuticals. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, valued at up to $999,999,999.00 through December 31, 2025, to deliver a comprehensive range of medications and medical supplies to DLA...
- This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,947.00, is for the delivery of GEL-ONE 30 MG/3 ML SYRINGE 3ML medical supplies. The contract has an ultimate completion date of June 6, 2025 and was awarded on May 15, 2025. Amerisourcebergen Drug Corp is an experienced federal contractor, holding a significant...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the supply of a specific pharmaceutical product, GEL-ONE 30 MG/3 ML SYRINGE 3ML, with a ceiling value of $3,527.20 and a performance period through April 23, 2024. The contract is a firm fixed price delivery order with no set-aside...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $10,947.00 firm fixed-price contract is for the supply of GEL-ONE 30 MG/3 ML SYRINGE 3ML medical products, with a completion date of February 24, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical to provide a comprehensive range of...
- The Defense Logistics Agency Troop Support Medical awarded a $5,264.25 firm fixed price delivery order contract to Amerisourcebergen Drug Corporation for 4561607491 GEL-ONE 30 MG/3 ML SYRINGE 3ML pharmaceutical products. Performance will take place at Amerisourcebergen's facility located in Conshohocken, Pennsylvania, spanning from July 17, 2023 through August 7, 2023. As a major provider of medical supplies and pharmaceuticals to the U.S. Department of Defense, this delivery order supports...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSBSEDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $10,947.00 to AmerisourceBergen Drug Corp for the supply of Gel-One 30 mg/3 mL syringes on July 28, 2025, with completion scheduled for August 18, 2025. This firm fixed-price delivery order, placed under a competitive procurement with no set-aside designation, will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. Gel-One is a viscosupplementation product used primarily for joint pain management, reflecting the Defense Logistics Agency's ongoing procurement of pharmaceutical and medical supply products to support military healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen Drug Corp serves as a prime vendor for the Defense Health Agency and other government healthcare systems, supplying a comprehensive range of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. The company's extensive contract portfolio with the DLA demonstrates its capability to meet federal procurement requirements and support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.9k | 7/28/25 |